0001213900-23-092817.txt : 20231204
0001213900-23-092817.hdr.sgml : 20231204
20231204172813
ACCESSION NUMBER: 0001213900-23-092817
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231201
FILED AS OF DATE: 20231204
DATE AS OF CHANGE: 20231204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patane Michael A
CENTRAL INDEX KEY: 0002002987
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 231464460
MAIL ADDRESS:
STREET 1: 6 WESTWIND ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0508
4
2023-12-01
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0002002987
Patane Michael A
1751 RIVER RUN, SUITE 400
FORT WORTH
TX
76107
1
0
0
0
0
Stock Options (Right to Buy)
0.36
2023-12-01
4
A
0
132442
0
A
2024-12-01
2033-12-01
Common Stock
132442
132442
D
The options vest and first become exercisable in 36 equal monthly installments, with the first installment vesting on December 1, 2024 and the remaining installments on the 1st of the month for the next 35 months.
/s/ Michael A Patane
2023-12-01